HPLC analysis of metabolically produced formaldehyde

Area of Science:

• Pharmacology
• Biochemistry
• Toxicology

Background:

• (-)-Deprenyl is a drug used in treating Parkinson's disease and depression.
• Metabolism of drugs can produce reactive intermediates, such as formaldehyde.
• Oxidative stress is implicated in aging and various diseases.

Purpose of the Study:

• To investigate the metabolic fate of radiolabelled (-)-deprenyl in rats.
• To quantify the urinary excretion of formaldehyde following oral administration of (-)-deprenyl.
• To explore the potential physiological role of low-level formaldehyde.

Main Methods:

• Oral administration of radiolabelled (-)-deprenyl to rats.
• Collection and analysis of rat urine samples.
• High-performance liquid chromatography (HPLC) with UV detection and radioactivity measurement to separate and quantify formaldehyde.
• Derivatization of formaldehyde with dinitrophenylhydrazine for detection.

Main Results:

• Radiolabelled formaldehyde was detected in the urine of rats treated with (-)-deprenyl.
• Formaldehyde was generated through the N-demethylation pathway of (-)-deprenyl.
• HPLC analysis confirmed the presence and quantity of the formaldehyde peak.

Conclusions:

• Oral administration of (-)-deprenyl leads to the metabolic generation and urinary excretion of formaldehyde in rats.
• The N-demethylation of (-)-deprenyl is a significant metabolic pathway producing formaldehyde.
• The findings suggest that endogenous formaldehyde, at low levels, may play a role in mitigating oxidative stress.